关注
László Forgách
László Forgách
PhD hallgató, Semmelweis Egyetem
在 med.semmelweis-univ.hu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Scale-up of electrospinning: Market overview of products and devices for pharmaceutical and biomedical purposes
S Omer, L Forgách, R Zelkó, I Sebe
Pharmaceutics 13 (2), 286, 2021
1492021
Fluorescent, prussian blue-based biocompatible nanoparticle system for multimodal imaging contrast
L Forgách, N Hegedűs, I Horváth, B Kiss, N Kovács, Z Varga, G Jakab, ...
Nanomaterials 10 (9), 1732, 2020
62020
A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells
A Kegler, L Drewitz, C Arndt, C Daglar, L Rodrigues Loureiro, N Mitwasi, ...
Frontiers in Immunology 14, 1204543, 2023
42023
Development of Polymer-Encapsulated, Amine-Functionalized Zinc Ferrite Nanoparticles as MRI Contrast Agents
ÁM Ilosvai, L Forgách, N Kovács, F Heydari, K Szigeti, D Máthé, F Kristály, ...
International Journal of Molecular Sciences 24 (22), 16203, 2023
22023
Synthesis and preclinical application of a Prussian blue-based dual fluorescent and magnetic contrast agent (CA)
N Hegedűs, L Forgách, B Kiss, Z Varga, B Jezsó, I Horváth, N Kovács, ...
Plos one 17 (7), e0264554, 2022
22022
Scale-up of Electrospinning: Market Overview of Products and Devices for Pharmaceutical and Biomedical Purposes. Pharmaceutics 2021, 13, 286
S Omer, L Forgách, R Zelkó, I Sebe
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
12021
Synthesis and preclinical application of a Prussian blue-based dual fluorescent and magnetic contrast agent (CA)(vol 17, e0264554, 2022)
N Hegedus, L Forgach, B Kiss, Z Varga, B Jezso, I Horvath, N Kovacs, ...
PLOS ONE 18 (11), 2023
2023
Correction: Synthesis and preclinical application of a Prussian blue-based dual fluorescent and magnetic contrast agent (CA)
N Hegedűs, L Forgách, B Kiss, Z Varga, B Jezsó, I Horváth, N Kovács, ...
Plos one 18 (11), e0295460, 2023
2023
DEVELOPMENT OF A NOVEL ACE2 DECOY FOR BOTH SARS-COV-2 VARIANT NEUTRALIZATION AND INFECTED CELL ELIMINATION VIA UNMODIFIED OR CAR MODIFIED IMMUNE CELLS
L Drewitz, A Kegler, C Arndt, C Daglar, LR Loureiro, N Mitwasi, C Neuber, ...
HUMAN GENE THERAPY 34 (21-22), A34-A34, 2023
2023
Prussian blue nanoparticles as isotope-labeled and fluorescent contrast material
L Forgách, N Kiss-Hegedus, Z Varga, N Kovacs, I Horváth, D Mathe, ...
Biophysical Journal 122 (3), 551a, 2023
2023
Development, in vitro characterization & in vivo testing of multimodal nanoparticles in an animal model
L Forgách
2023
Prussian blue nanoparticles: an advanced platform for multimodal imaging
L Forgách, N Kiss-Hegedus, I Horváth, K Szigeti, D Máthé
Biophysical Journal 121 (3), 425a-426a, 2022
2022
Novel fluorescent Labelled, Pegylated Prussian Blue Nanoparticles for in vivo Optical Imaging
L Forgách, N Hegedűs, I Horváth, K Szigeti, D Máthé
Acta Pharmaceutica Hungarica 91 (3-4), 216-217, 2021
2021
Novel magnetic Prussian Blue nanoparticles for in vivo T1 MR-imaging
L Forgách, N Hegedűs, I Horváth, K Szigeti, D Máthé
Acta Pharmaceutica Hungarica 91 (3-4), 214-215, 2021
2021
The 3M Concept: Biomedical Translational Imaging from Molecules to Mouse to Man
D Máthé, B Kiss, B Pályi, Z Kis, L Forgách, N Hegedűs, Z Varga, K Szigeti, ...
The EuroBiotech Journal 5 (3), 155-160, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–15